List your tool

Head to head · 2026

PathAI vs Rayscape

Pricing, free plans, ratings, features, pros and cons, side by side. Where one comes out ahead, we mark it.

PathAI

First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp

4.3Not listed

Visit PathAI (opens PathAI in a new tab)

Rayscape

FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical…

3.7Not listed

Visit Rayscape (opens Rayscape in a new tab)

Who comes out ahead

Based only on the facts in our directory. The right pick still depends on the job you need done.

  • Lower starting price

    Not comparable

    Not comparable: PathAI does not list a price

  • Free plan

    Tie

    Neither has one

  • Higher rating

    PathAI

    4.3 against 3.7

  • Same job?

    Yes

    Both are Healthcare AI tools

Side by side

Compared onPathAIRayscape
Our rating4.3Better3.7
Starts atNot listedNot listed
Free planNoNo
CategoryHealthcare AIHealthcare AI
PlansSee pricingSee pricing
Key features
  • AISight Dx analyzes digital pathology slide images to assist diagnosis
  • FDA 510(k) clearance for primary diagnosis in clinical settings, June 2025
  • Predetermined Change Control Plan allows faster future software updates
  • Expanded Labcorp collaboration deploying nationwide as of February 2026
  • FDA Breakthrough Device Designation for PathAssist Derm dermatopathology tool
  • 148+ pathology detection on chest X-rays
  • Pulmonary nodule detection, measurement, and tracking on lung CT
  • Multiple FDA clearances and extensive clinical validation
  • Trained on a 42M+ medical image database
  • Study urgency prioritization and structured report generation
Pros
  • Genuine FDA clearance for primary diagnosis, not just an assistive tool
  • Predetermined Change Control Plan speeds up future regulatory-approved updates
  • National-scale deployment through Labcorp validates real clinical trust
  • Genuine regulatory clearance (FDA) rather than just a marketing claim
  • Named, specific clinical capabilities rather than vague AI-diagnosis language
  • Independent Health AI Register listing adds third-party verification
Cons
  • Enterprise quote-based pricing requires a sales conversation, no published rates
  • Built specifically for pathology labs, not applicable to other clinical specialties
  • Regulatory-cleared medical device status means slower iteration than software-only tools
  • Pricing isn't public - requires direct institutional engagement
  • Built for clinical integration, not accessible to individual patients directly
  • AI-assisted findings still require radiologist review and final sign-off
CompanyPathAI, founded 2016Rayscape

Prices come from each vendor's pricing page, last checked 20260826. Check the vendor before you buy.

FAQ

Questions people ask

Is PathAI better than Rayscape?

In our reviews PathAI scores 4.3 and Rayscape scores 3.7. The better pick depends on the job. PathAI: First AI pathology platform FDA-cleared for primary diagnosis, now deployed nationwide via Labcorp. Rayscape: FDA-cleared AI that reads chest X-rays and lung CTs for 148+ pathologies, trained on 42M+ medical images - detects, measures, and tracks pulmonary nodules from 3 to 30mm.

Which is cheaper, PathAI or Rayscape?

PathAI: see pricing. Rayscape: see pricing.

Do PathAI and Rayscape have free plans?

Neither lists a free plan.

More comparisons